These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33869004)

  • 1.
    Li Z; Langhans SA
    Front Oncol; 2021; 11():620831. PubMed ID: 33869004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials using molecular stratification of pediatric brain tumors.
    Hanz SZ; Adeuyan O; Lieberman G; Hennika T
    Transl Pediatr; 2020 Apr; 9(2):144-156. PubMed ID: 32477915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
    Pollack IF
    J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
    Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
    Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
    Foster JB; Griffin C; Rokita JL; Stern A; Brimley C; Rathi K; Lane MV; Buongervino SN; Smith T; Madsen PJ; Martinez D; Delaidelli A; Sorensen PH; Wechsler-Reya RJ; Karikó K; Storm PB; Barrett DM; Resnick AC; Maris JM; Bosse KR
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy.
    Klein E; Hau AC; Oudin A; Golebiewska A; Niclou SP
    Front Oncol; 2020; 10():604121. PubMed ID: 33364198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells.
    Azzarelli R
    Front Cell Dev Biol; 2020; 8():220. PubMed ID: 32373607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of glioblastoma organoids and their applications in personalized therapy.
    Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
    Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.
    Endersby R; Whitehouse J; Hii H; Greenall SA; Johns TG; Gottardo NG
    Neoplasia; 2018 May; 20(5):432-442. PubMed ID: 29574250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors.
    Xiong A; Spyrou A; Forsberg-Nilsson K
    Adv Exp Med Biol; 2020; 1221():365-403. PubMed ID: 32274718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
    Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric low-grade glioma models: advances and ongoing challenges.
    Yvone GM; Breunig JJ
    Front Oncol; 2023; 13():1346949. PubMed ID: 38318325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the biology and treatment of pediatric central nervous system tumors.
    Vitanza NA; Cho YJ
    Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
    Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
    Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.